ABT · earnings call history
Abbott Q2 FY26 — Strong Sales Acceleration and Raised EPS Guidance
Read the briefAbbott Q1 FY26 — In-line start; Exact Sciences closes as respiratory season and CGM soften
Read the briefAbbott Q4 FY25 — Strong MedTech and Diabetes Growth Offset Nutrition Challenges
Read the briefAbbott Q3 FY25 — Strong Medical Device Growth and Positive 2026 Outlook
Read the briefAbbott Q1 FY25 — Strong Performance Despite Tariffs and Macro Headwinds
Read the briefBrowse all US companies on the earnings-call register.